AMMF joins Cancer52
AMMF is delighted to have become a member of Cancer52, the organization providing a “common voice for the less common cancers”.
Cancer52 is so named because 52% of cancer deaths in the UK are from the less common cancers (although in 2010 this proportion increased to 53%). Despite this figure, the less common cancers remain severely under represented and under funded across all areas, including policy, services and research.
Cancer52 is an alliance of over 40 organisations working to address these inequalities and to improve outcomes for patients with these highly challenging diseases.
Together we have a more powerful voice.